**POSTPONED** Neurological diseases: From Science to Business

Neurological disorders affect almost a billion persons worldwide. With the aging of the population, this figure will continue to increase.
Although the scientific factor is the main challenge in treating these diseases it is not the whole story.

In this meetup, we will host Prof. Ilana Gozes from Tel Aviv University who will share with us the latest advances that overcome the crossing BBB challenge.
Shiran Zimri will screen the currently available solutions in the market for Parkinson's and Alzheimer's diseases and the future direction.
Alon Ben-Noon, the CEO of NeuroSense therapeutics, who recently initiated a Phase II study in ALS patients, will share with us his inside business insights.

"Crossing the BBB- towards solving the challenges"
Prof. Ilana Gozes. Ilana is a Professor of Clinical Biochemistry at the Sackler Faculty of Medicine in Tel Aviv University and a CSO in Coronis Neuroscience.

"Unraveling the X Factor in neurodegenerative diseases" - Dr. Shiran Zimri, Tel-Aviv University. Shiran has over 10 years of experience in Neuroscience focusing on neurogenerative disease, specifically Alzheimer's.

"The way to a breakthrough in Neurodegenerative diseases" - Alon Ben-Noon, CEO NeuroSense Therapeutics

Yours,
Helen Domeshek, PhD
Business Development
...............................................
Recipharm Israel
Address: Hamazmera 9 | Ness Ziona | Israel
Phone: +972 8 9293843 (Direct) | +972-54-764-3763 (Mobile)
www.recipharm.com